Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/07/18 → 31/01/21 |
Funding
- UK-based charities: £49,000.00
In vivo validation of Semaphorin3A-Neuropilin1 as a therapeutic target for Multiple Sclerosis.
- Williams, Anna (Principal Investigator)
| Status | Finished |
|---|---|
| Effective start/end date | 4/07/18 → 31/01/21 |